Man Group’s Iovance Biotherapeutics IOVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-37,758
| Closed | -$126K | – | 2034 |
|
|
2025
Q1 | $126K | Sell |
37,758
-2,377,238
| -98% | -$7.92M | ﹤0.01% | 1864 |
|
|
2024
Q4 | $17.9M | Buy |
+2,414,996
| New | +$17.9M | 0.05% | 411 |
|
|
2024
Q2 | – | Sell |
-80,583
| Closed | -$1.19M | – | 1992 |
|
|
2024
Q1 | $1.19M | Buy |
80,583
+68,964
| +594% | +$1.02M | ﹤0.01% | 1363 |
|
|
2023
Q4 | $94.5K | Buy |
+11,619
| New | +$94.5K | ﹤0.01% | 1861 |
|
|
2023
Q3 | – | Sell |
-91,301
| Closed | -$643K | – | 1599 |
|
|
2023
Q2 | $643K | Buy |
+91,301
| New | +$643K | ﹤0.01% | 1479 |
|
|
2023
Q1 | – | Sell |
-49,104
| Closed | -$314K | – | 1344 |
|
|
2022
Q4 | $314K | Buy |
49,104
+31,159
| +174% | +$199K | ﹤0.01% | 1633 |
|
|
2022
Q3 | $172K | Buy |
+17,945
| New | +$172K | ﹤0.01% | 1754 |
|
|
2022
Q2 | – | Hold |
0
| – | – | – | 1779 |
|
|
2020
Q3 | – | Sell |
-235,704
| Closed | -$6.47M | – | 1818 |
|
|
2020
Q2 | $6.47M | Buy |
235,704
+217,854
| +1,220% | +$5.98M | 0.03% | 551 |
|
|
2020
Q1 | $534K | Sell |
17,850
-14,068
| -44% | -$421K | ﹤0.01% | 1262 |
|
|
2019
Q4 | $883K | Sell |
31,918
-50,365
| -61% | -$1.39M | ﹤0.01% | 1509 |
|
|
2019
Q3 | $1.5M | Buy |
+82,283
| New | +$1.5M | 0.01% | 1328 |
|